Skip to main content
. 2017 Nov 8;39(3):407–417. doi: 10.1093/carcin/bgx122

Figure 4.

Figure 4.

KM plotter predicted poorer OS of ovarian cancer patients patients with high expression of RAD51AP1 (A), FSTL1 (B) and COL12A1 (C) but not SPRR1A (D). When KM plots were applied for lung cancer patients, poorer OS was predicted with high expression of RAD51AP1 (E), and SPRR1A (H), and with low expression of FSTL1 (F), whereas COL12A1 was not a predictor (G).